Sanket Koul, Business Standard

Stories by Sanket Koul, Business Standard

Indian HNIs maintain grip on Dubai luxury real estate despite West Asia tensions

Indian HNIs maintain grip on Dubai luxury real estate despite West Asia tensions

Rediff.com   3 days ago

Ongoing geopolitical tensions in West Asia have slowed deal momentum in Dubai's luxury residential market, but Indian high-net-worth individuals (HNIs) are not exiting their marquee assets, with any 'discounted' resale deals attributed to investor liquidity stress rather than geopolitical flight.

Jio IPO Set To Break All Records

Jio IPO Set To Break All Records

Rediff.com   6 days ago

Only 2.5 per cent of the equity in Jio Platforms will be offloaded through the OFS route -- meant for secondary share sale.

Noida International Airport: Property Prices Soar Along Yamuna Expressway

Noida International Airport: Property Prices Soar Along Yamuna Expressway

Rediff.com   30 Mar 2026

The inauguration of Noida International Airport (NIA) is set to significantly increase property values in micro-markets along the Yamuna Expressway, with projections indicating a 28 per cent rise for plots and 22 per cent for apartments over the next two years, according to Colliers.

Goldman Cuts India Market Outlook

Goldman Cuts India Market Outlook

Rediff.com   27 Mar 2026

Goldman Sachs has materially lowered its earnings growth forecast for Indian companies by a cumulative 9 percentage points over the next two years.

Hiring Outlook Brightens for FY27

Hiring Outlook Brightens for FY27

Rediff.com   26 Mar 2026

Hiring demand strongest in ecommerce, tech startups, healthcare, and energy sectors, with Bengaluru, Hyderabad, and Pune leading.

Centre Cracks Down on GLP-1 Drug Misuse

Centre Cracks Down on GLP-1 Drug Misuse

Rediff.com   25 Mar 2026

Inspections conducted across 49 entities including pharmacies, wholesalers, and clinics to detect violations and misleading marketing practices.

Semaglutide Ruling Sparks Generic Pharma Boom

Semaglutide Ruling Sparks Generic Pharma Boom

Rediff.com   24 Mar 2026

At the heart of this debate is Section 3(d) of the Patents Act, a safeguard designed to prevent drugmakers from extending monopoly protection through trivial modifications to existing medicines.

Reality check gets India on investors' realty list

Reality check gets India on investors' realty list

Rediff.com   23 Mar 2026

Escalating geopolitical tensions in West Asia are prompting investors with exposure to Dubai's real estate market to reassess their portfolios. And, in this rejig, India is emerging as a stable destination for capital investment and long-term growth.

'No Governance Issue In HDFC Bank'

'No Governance Issue In HDFC Bank'

Rediff.com   20 Mar 2026

'Being an important institution in the banking system, we are subject to regulatory supervision, both offsite and onsite.' 'When you look at the intensity at which these levels of supervision come, we, on the board and in management, believe there should not be any surprises.'

Weight Loss Drugs Set to Flood India

Weight Loss Drugs Set to Flood India

Rediff.com   16 Mar 2026

While the introduction of branded generics is likely to accelerate volumes for GLP-1 agonists, value growth may moderate because of price erosion.

US Business Schools Eye India Partnerships

US Business Schools Eye India Partnerships

Rediff.com   12 Mar 2026

The outreach comes amid a drop in Indian student enrolments in management programmes at American universities last year, following changes to US student visa policies.

Obesity Drug Can't Be Advertised Anymore

Obesity Drug Can't Be Advertised Anymore

Rediff.com   12 Mar 2026

'Any promotional activity carried out under the pretext of disease awareness, influencer engagement, corporate campaigns, or similar activities that create brand recall/product visibility of the prescription shall also be treated as violations.'

India Targets 200,000 Foreign Students by 2030

India Targets 200,000 Foreign Students by 2030

Rediff.com   11 Mar 2026

The government has intensified its Study in India programme and is working closely with universities and states to achieve this goal.

Abbott Bets On Semaglutide Boom

Abbott Bets On Semaglutide Boom

Rediff.com   28 Feb 2026

Abbott will exclusively distribute and market Extensior in the country, becoming the second company to secure sole distribution rights for Novo's semaglutide portfolio in India, after Emcure Pharma.

CDSCO allows immediate lab testing of drugs to speed up approvals

CDSCO allows immediate lab testing of drugs to speed up approvals

Rediff.com   27 Feb 2026

The Centre has allowed companies to begin lab testing immediately after filing applications instead of waiting for detailed scrutiny, in a move to expedite approvals for manufacture, or import of new drugs.

'You End Up Firefighting': Finance Minister

'You End Up Firefighting': Finance Minister

Rediff.com   26 Feb 2026

'Uncertainty level A in the morning, uncertainty level B in the afternoon. If I answer about tariff rates now, I'll be outdated by the evening.'

'India Is A Reverse AI Trade Globally'

'India Is A Reverse AI Trade Globally'

Rediff.com   25 Feb 2026

'The day that the market realises that they've overspent (on AI) and there's a sudden collapse in the capex, then India can start outperforming again.'

Gurugram Dethrones Mumbai As India's Luxury Housing Capital

Gurugram Dethrones Mumbai As India's Luxury Housing Capital

Rediff.com   24 Feb 2026

Gurugram has overtaken Mumbai to become India's biggest luxury housing market in 2025, recording 24,120 crore in sales of homes priced above 10 crore.

Empty PG Seats, Missing Doctors

Empty PG Seats, Missing Doctors

Rediff.com   23 Feb 2026

'When young doctors see limited protection, unpredictable careers and an absence of institutional support, they hesitate.'

AI Can Make India World's Creative Capital

AI Can Make India World's Creative Capital

Rediff.com   21 Feb 2026

'Not the back office for the world's content. The leader. The standard-setter.'